{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?page=2&sponsor=Novavax", "query": { "sponsor": "Novavax", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 34, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?page=3&sponsor=Novavax&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?page=1&sponsor=Novavax&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-06T13:34:13.253Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02608502", "title": "A Study to Evaluate the Efficacy of an RSV F Vaccine in Older Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Respiratory Syncytial Virus (RSV)" ], "interventions": [ { "name": "RSV-F Vaccine", "type": "BIOLOGICAL" }, { "name": "Phosphate Buffer Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Novavax", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 11850, "start_date": "2015-11", "completion_date": "2016-12", "has_results": false, "last_update_posted_date": "2022-07-19", "last_synced_at": "2026-10-06T13:34:13.253Z", "location_count": 60, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Mesa, Arizona + 51 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02608502" }, { "nct_id": "NCT01014806", "title": "Evaluate the Safety and Immunogenicity of a Seasonal Influenza Virus-Like Particle (VLP) Vaccine in Older Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "Influenza VLP Vaccine", "type": "BIOLOGICAL" }, { "name": "TIV", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Novavax", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 467, "start_date": "2009-11", "completion_date": "2010-05", "has_results": false, "last_update_posted_date": "2013-07-18", "last_synced_at": "2026-10-06T13:34:13.253Z", "location_count": 6, "location_summary": "Pembroke Pines, Florida • Rochester, Minnesota • Providence, Rhode Island + 3 more", "locations": [ { "city": "Pembroke Pines", "state": "Florida" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "Providence", "state": "Rhode Island" }, { "city": "Mt. Pleasant", "state": "South Carolina" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01014806" }, { "nct_id": "NCT07086222", "title": "Efficacy and Safety of NVX-CoV2705", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "COVID-19", "Sars-CoV-2 Infection" ], "interventions": [ { "name": "NVX-CoV2705", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Novavax", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "50 Years to 65 Years" }, "enrollment_count": 6500, "start_date": "2025-11-20", "completion_date": "2026-11-18", "has_results": false, "last_update_posted_date": "2026-05-08", "last_synced_at": "2026-10-06T13:34:13.253Z", "location_count": 99, "location_summary": "Athens, Alabama • Birmingham, Alabama • Gadsden, Alabama + 88 more", "locations": [ { "city": "Athens", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Gadsden", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT07086222" }, { "nct_id": "NCT03293498", "title": "Evaluation of the Safety and Immunogenicity of a Recombinant Trivalent Nanoparticle Influenza Vaccine With Matrix M-1 Adjuvant (NanoFlu)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "NanoFlu", "type": "BIOLOGICAL" }, { "name": "Fluzone HD - Day 0", "type": "BIOLOGICAL" }, { "name": "Fluzone HD - Day 21", "type": "BIOLOGICAL" }, { "name": "Saline - Day 21", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Novavax", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 330, "start_date": "2017-09-18", "completion_date": "2018-10-29", "has_results": true, "last_update_posted_date": "2022-12-21", "last_synced_at": "2026-10-06T13:34:13.253Z", "location_count": 3, "location_summary": "Raleigh, North Carolina • Rocky Mount, North Carolina • Statesville, North Carolina", "locations": [ { "city": "Raleigh", "state": "North Carolina" }, { "city": "Rocky Mount", "state": "North Carolina" }, { "city": "Statesville", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03293498" }, { "nct_id": "NCT05925127", "title": "Phase 2/3 Heterologous Boosting Study With Different Dose Levels of Monovalent SARS-CoV-2 rS Vaccines", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "COVID-19" ], "interventions": [ { "name": "NVX-CoV2373 (5μg)", "type": "BIOLOGICAL" }, { "name": "NVX-CoV2601(5μg)", "type": "BIOLOGICAL" }, { "name": "NVX-CoV2601(35μg)", "type": "BIOLOGICAL" }, { "name": "NVX-CoV2601(50μg)", "type": "BIOLOGICAL" }, { "name": "Bivalent BA.4/5", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Novavax", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "50 Years to 99 Years" }, "enrollment_count": 994, "start_date": "2023-10-16", "completion_date": "2024-05-21", "has_results": false, "last_update_posted_date": "2024-12-13", "last_synced_at": "2026-10-06T13:34:13.253Z", "location_count": 50, "location_summary": "Birmingham, Alabama • Tucson, Arizona • Banning, California + 44 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Banning", "state": "California" }, { "city": "Chula Vista", "state": "California" }, { "city": "La Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05925127" }, { "nct_id": "NCT02247726", "title": "RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Respiratory Syncytial Virus Infections" ], "interventions": [ { "name": "Saline Placebo (0.5mL injection)", "type": "DRUG" }, { "name": "RSV F vaccine (0.5mL injection)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novavax", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "FEMALE", "summary": "18 Years to 40 Years · Female only" }, "enrollment_count": 50, "start_date": "2014-09", "completion_date": "2016-07", "has_results": false, "last_update_posted_date": "2022-05-27", "last_synced_at": "2026-10-06T13:34:13.253Z", "location_count": 7, "location_summary": "Nampa, Idaho • Hutchinson, Kansas • Kansas City, Kansas + 4 more", "locations": [ { "city": "Nampa", "state": "Idaho" }, { "city": "Hutchinson", "state": "Kansas" }, { "city": "Kansas City", "state": "Kansas" }, { "city": "Norfolk", "state": "Nebraska" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02247726" }, { "nct_id": "NCT00754455", "title": "Evaluate the Safety and Immunogenicity of a Seasonal Influenza VLP Vaccine (Recombinant) in Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "Influenza VLP Vaccine (recombinant)", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Novavax", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 317, "start_date": "2008-09", "completion_date": "2009-03", "has_results": false, "last_update_posted_date": "2013-07-18", "last_synced_at": "2026-10-06T13:34:13.253Z", "location_count": 4, "location_summary": "Pembroke Pines, Florida • Kansas City, Missouri • Warwick, Rhode Island + 1 more", "locations": [ { "city": "Pembroke Pines", "state": "Florida" }, { "city": "Kansas City", "state": "Missouri" }, { "city": "Warwick", "state": "Rhode Island" }, { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00754455" }, { "nct_id": "NCT05975060", "title": "A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "COVID-19" ], "interventions": [ { "name": "XBB.1.5 Vaccine (Booster)", "type": "BIOLOGICAL" }, { "name": "XBB.1.5 Vaccine (single dose)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Novavax", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "54 Years", "sex": "ALL", "summary": "18 Years to 54 Years" }, "enrollment_count": 660, "start_date": "2023-09-07", "completion_date": "2024-05-20", "has_results": false, "last_update_posted_date": "2024-05-30", "last_synced_at": "2026-10-06T13:34:13.253Z", "location_count": 30, "location_summary": "Mobile, Alabama • Sacramento, California • Colorado Springs, Colorado + 26 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Sacramento", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "Fort Myers", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05975060" }, { "nct_id": "NCT07079670", "title": "Safety and Immunogenicity of NVX-CoV2705", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "COVID-19", "SARS-CoV-2 Infection" ], "interventions": [ { "name": "NVX-CoV2705", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "12 Years to 90 Years" }, "enrollment_count": 676, "start_date": "2025-10-09", "completion_date": "2026-05-11", "has_results": false, "last_update_posted_date": "2026-06-05", "last_synced_at": "2026-10-06T13:34:13.253Z", "location_count": 10, "location_summary": "Phoenix, Arizona • Melrose Park, Illinois • Lenexa, Kansas + 7 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Melrose Park", "state": "Illinois" }, { "city": "Lenexa", "state": "Kansas" }, { "city": "Lafayette", "state": "Louisiana" }, { "city": "Southfield", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT07079670" }, { "nct_id": "NCT06027229", "title": "Additional Recombinant COVID-19 Humoral and Cell-Mediated Immunogenicity in Immunosuppressed Populations", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Immunosuppression", "COVID-19" ], "interventions": [ { "name": "NVX-CoV2372", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "University of Wisconsin, Madison", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 21, "start_date": "2023-11-20", "completion_date": "2024-09-09", "has_results": true, "last_update_posted_date": "2025-10-20", "last_synced_at": "2026-10-06T13:34:13.253Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT06027229" } ] }